PHAT Stock Summary and Trading Ideas (Phathom Pharmaceuticals | NASDAQ:PHAT)

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

What symbol and exchange does Phathom Pharmaceuticals shares trade?

Phathom Pharmaceuticals trades on the NASDAQ stock market under the symbol PHAT.

What is Phathom Pharmaceuticals stock price doing today?

As of February 4, 2026, PHAT stock price declined to $13.23 with 946,546 million shares trading.

What is Phathom Pharmaceuticals's Beta?

PHAT has a beta of 2.26, meaning it tends to be more sensitive to market movements. PHAT has a correlation of 0.11 to the broad based SPY ETF.

How much is Phathom Pharmaceuticals worth?

PHAT has a market cap of $1.03 billion. This is considered a Small Cap stock.

How much money does Phathom Pharmaceuticals make?

Last quarter Phathom Pharmaceuticals reported $50 million in Revenue and -$.15 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.26.

What is the highest and lowest price Phathom Pharmaceuticals traded in the last 3 year period?

In the last 3 years, PHAT traded as high as $19.71 and as low as $2.21.

What are the top ETFs holding Phathom Pharmaceuticals?

The top ETF exchange traded funds that PHAT belongs to (by Net Assets): VTI, IWM, VXF, IBB, XPH.

Is Phathom Pharmaceuticals (PHAT) a good investment?

PHAT has outperformed the market in the last year with a return of +135.0%, while the SPY ETF gained +16.0%. However, in the most recent history, PHAT shares have underperformed the stock market with its stock returning -3.6% in the last 3 month period and -6.5% for the last 2 week period, while SPY has returned +0.7% and +1.3%, respectively.

What are the support and resistance levels for Phathom Pharmaceuticals (PHAT)?

PHAT support price is $13.07 and resistance is $14.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHAT shares will trade within this expected range on the day.